🎙️ Episode Title: Muscle, Metabolism & Motion: Aging Well with Arny Ferrando

In this powerhouse episode, we’re joined by Arny Ferrando, world-leading expert in muscle metabolism and aging from University of Arkansas Medical Sciences. We recount his journey through West Point, Ranger School, aviation, and NASA, on to becoming a leading researcher in his field.

We dive into:

• ✅ TRT (Testosterone Replacement Therapy) — What it is, when it's needed, and why it’s not just about performance
• 🧬 Sarcopenia and aging — Why muscle loss accelerates over 40, and how to fight it with resistance training and protein
• 🥩 Essential Amino Acids (EAAs) — What dozens of clinical studies say about this underappreciated tool
• 🛌 Sleep, stress, and recovery — Lessons from tactical athletes and special operators
• 💥 Supplements that work (and those that mostly don’t…) — The real science behind EAAs, creatine, beta alanine, and a bunch of also-rans
• 🚀 His most famous and favorite research subject — Marine Colonel, Senator, and astronaut John Glenn

🗣️ Final takeaway: “Motion is lotion.” Keep moving! Nothing gets better with age, but movement and nutrition go a long way.

Dr. Dan Jacobazzi is a world class chiropractor and physical therapist.

I know firsthand. He’s put me back together more times than I care to remember after my various injuries and surgeries.

What might be more surprising is how much more than that he is. An accomplished division one athlete who started off in engineering before transitioning to healthcare, he’s expanded into wholistic medicine with an emphasis on gut health and inflammation—the root of a lot of Modern Industrial Diseases (MIDs).

In this episode, we dig into his journey and the sad state of modern sickcare and what to do about it, including misconceptions about cholesterol and statins, high blood pressure, and the next big shoe to drop—GLP-1 agonists and their side effects.

We also discuss entrepreneurship, independence, and some truly novel tax strategies…

This episode is just the chaser for that red pill!

In this episode, Andy and Stavros unpack the cost, cause, and complexity of Modern Industrial Diseases (MIDs)—a catchall Andyism for lifestyle-driven conditions like obesity, hypertension, and Type 2 diabetes. They explore GLP-1 agonists (Ozempic, Wegovy) as promising but costly interventions, while questioning the real ROI of weight loss drugs in public health.

The conversation moves from Medicare data and NHANES statistics to the failure of corporate wellness programs, and why only 5% of people are ever able to sustain real lifestyle changes. If you're curious about what’s really driving the chronic illness epidemic in developed countries—and what it costs us as individuals and a society—this is your episode.